Pathogenesis and Management of Graft-versus-Host Disease
- 28 February 2010
- journal article
- review article
- Published by Elsevier BV in Immunology and Allergy Clinics of North America
- Vol. 30 (1), 75-101
- https://doi.org/10.1016/j.iac.2009.10.001
Abstract
No abstract availableKeywords
This publication has 128 references indexed in Scilit:
- Prophylaxis regimens for GVHD: systematic review and meta-analysisBone Marrow Transplantation, 2008
- Treatment of refractory acute GVHD with third-party MSC expanded in platelet lysate-containing mediumBone Marrow Transplantation, 2008
- Extracorporeal photopheresis for the treatment of steroid refractory acute GVHDBone Marrow Transplantation, 2008
- Pathophysiology of acute graft-versus-host disease: recent advancesTranslational Research, 2007
- Toll-like receptor control of the adaptive immune responsesNature Immunology, 2004
- Integrins and T Cell–Mediated ImmunityAnnual Review of Immunology, 2004
- Tacrolimus vs. cyclosporine immunosuppression: Results in advanced-stage disease compared with historical controls treated exclusively with cyclosporineTransplantation and Cellular Therapy, 1999
- MYCOPHENOLATE MOFETIL AND CYCLOSPORINE AS GRAFT-VERSUS-HOST DISEASE PROPHYLAXIS AFTER ALLOGENEIC BLOOD STEM CELL TRANSPLANTATIONTransplantation, 1999
- Placental Blood as a Source of Hematopoietic Stem Cells for Transplantation into Unrelated RecipientsNew England Journal of Medicine, 1996
- Methotrexate and Cyclosporine Compared with Cyclosporine Alone for Prophylaxis of Acute Graft versus Host Disease after Marrow Transplantation for LeukemiaNew England Journal of Medicine, 1986